Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
15.84
-0.11 (-0.69%)
At close: Aug 13, 2026, 4:00 PM EDT
16.11
+0.27 (1.68%)
After-hours: Aug 13, 2026, 7:34 PM EDT
Monte Rosa Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $28 | Buy | Reiterates | $28 | +76.77% | Aug 13, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $27 | Buy | Maintains | $27 | +70.45% | Aug 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $37 | Buy | Reiterates | $37 | +133.59% | Aug 7, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 7, 2026 |
| Wedbush | Wedbush | Buy Maintains $37 → $27 | Buy | Maintains | $37 → $27 | +70.45% | Aug 3, 2026 |
| Jefferies | Jefferies | Buy Maintains $25 | Buy | Maintains | $25 | +57.83% | Jul 31, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $29 | Buy | Reiterates | $29 | +83.08% | Jun 24, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 7, 2026 |